Systems and methods for preventing, managing and/or treating peripheral neuropathy, peripheral vascular disease, erectile dysfunction, urinary incontinence, cellulite and other conditions
Systems and methods for preventing, managing and/or treating peripheral neuropathy and peripheral vascular disease in a patient. The systems and methods include measuring, optimizing transmissibility and coordinating the delivery of pressure (e.g., sound) waves that are delivered using higher frequency RF band energy in a pulsed manner to carry the energy to larger areas of the patient's tissue. The pressure wave may be delivered at generally the same time a heart pulse beat of the patient is detected.
1. A method for treating peripheral neuropathy, peripheral vascular disease, erectile dysfunction, urinary incontinence, or cellulite in a patient, the method comprising:
administering RF energy to the patient over a range of RF frequencies;
detecting the administered RF energy with a RF antenna or an acoustic measuring device;
identifying, from the detection of the administered RF energy, which RF frequency of the range of RF frequencies has the greatest transmissibility through the patient;
recommending the identified RF frequency for use in further RF energy treatment to the patient;
administering the RF energy at the identified RF frequency to the patient over a range of pulse frequencies;
detecting electromyogram readings over the range of pulse frequencies with an EMG sensor;
identifying, from the detection of the electromyogram readings, which pulse frequency of the range of pulse frequencies results in the highest electromyogram readings in the patient;
recommending the identified pulse frequency for use in further RF energy treatment to the patient; and
administering the RF energy at the identified RF frequency and identified pulse frequency to the patient.
2. The method of claim 1 , wherein the administration of the RF energy to the patient over the range of frequencies is accomplished via a RF head having an array of piezoelectric transducers each tuned to an individual unique frequency, the array being configured to generate RF energy over a range of between 500 KHz and 1.5 MHz 1.5 MHz.
3. The method of claim 1 , wherein the administration of the RF energy to the patient over the range of frequencies is over a range of between 500 KHz and 1.5 MHz at steps of between 50 KHz and 200 KHz.
4. The method of claim 1 , wherein the recommending the identified RF frequency for use in further RF energy treatment to the patient includes identifying a specific RF head from a plurality of RF heads that is configured to provide the recommended RF frequency.
5. The method of claim 1 , wherein the administering the RF energy at the identified RF frequency to the patient over a range of pulse frequencies occurs over a pulse frequencies ranging between 1 Hz and 300 Hz programmatically controlled and optimized for tissue type via stored protocols.
6. The method of claim 1 , wherein the RF energy is administered to stimulate a parasympathetic where nerve roots of nerves exit a spinal column at T10, T11, L1, L2, S2, S3 and/or S4.
7. The method of claim 6 , wherein the administering the RF energy at the identified RE frequency to the patient over a range of pulse frequencies occurs over a pulse frequencies ranging between 1 Hz and 300 Hz.
8. The method of claim 7 , wherein the administration of the RF energy occurs in the context of treating erectile dysfunction.
9. The method of claim 8 , wherein the RF energy is used to stimulate the cavernous nerve.
10. The method of claim 7 , wherein the administration of the RF energy occurs in the context of treating urinary incontinence.
11. The method of claim 1 , wherein the administration of the RF energy occurs in the context of treating cellulite.